Alzheimer's Disease - Pipeline Review, H2 2018

Publisher Name :
Date: 07-Aug-2018
No. of pages: 1333
Inquire Before Buying

Alzheimer's Disease - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alzheimer's Disease - Pipeline Review, H2 2018, provides an overview of the Alzheimer's Disease (Central Nervous System) pipeline landscape.

Alzheimer's disease is a progressive, degenerative condition causing damage to the memory and behavior due to the attack on the neurons. These neurons are responsible for the synthesis of neurotransmitter acetylcholine which is further responsible for the transmission of signals. Predisposing factors include age, heredity, cardiovascular diseases or diabetes and environmental factors. Symptoms include depression, anxiety, social withdrawal, irritability and aggressiveness.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Alzheimer's Disease - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Alzheimer's Disease (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Alzheimer's Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alzheimer's Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 25, 56, 53, 3, 276, 102 and 11 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 1, 1, 104 and 41 molecules, respectively.

Alzheimer's Disease (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Alzheimer's Disease (Central Nervous System).

- The pipeline guide reviews pipeline therapeutics for Alzheimer's Disease (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Alzheimer's Disease (Central Nervous System) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Alzheimer's Disease (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Alzheimer's Disease (Central Nervous System)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Alzheimer's Disease (Central Nervous System).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Alzheimer's Disease (Central Nervous System) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Alzheimer's Disease - Pipeline Review, H2 2018

Table of Contents
Table of Contents 2
Introduction 11
Alzheimer's Disease - Overview 12
Alzheimer's Disease - Therapeutics Development 13
Alzheimer's Disease - Therapeutics Assessment 80
Alzheimer's Disease - Companies Involved in Therapeutics Development 107
Alzheimer's Disease - Drug Profiles 201
Alzheimer's Disease - Dormant Projects 1212
Alzheimer's Disease - Discontinued Products 1251
Alzheimer's Disease - Product Development Milestones 1258
Appendix 1270

List of Tables
Number of Products under Development for Alzheimer's Disease, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Alzheimer's Disease - Pipeline by AB Science SA, H2 2018
Alzheimer's Disease - Pipeline by AbbVie Inc, H2 2018
Alzheimer's Disease - Pipeline by AC Immune SA, H2 2018
Alzheimer's Disease - Pipeline by Accera Inc, H2 2018
Alzheimer's Disease - Pipeline by Actinogen Medical Ltd, H2 2018
Alzheimer's Disease - Pipeline by Acumen Pharmaceuticals Inc, H2 2018
Alzheimer's Disease - Pipeline by Addex Therapeutics Ltd, H2 2018
Alzheimer's Disease - Pipeline by Aequus Pharmaceuticals Inc, H2 2018
Alzheimer's Disease - Pipeline by Affichem SA, H2 2018
Alzheimer's Disease - Pipeline by AFFiRiS AG, H2 2018
Alzheimer's Disease - Pipeline by Alector LLC, H2 2018
Alzheimer's Disease - Pipeline by Allergan Plc, H2 2018
Alzheimer's Disease - Pipeline by Allgenesis Biotherapeutics Inc, H2 2018
Alzheimer's Disease - Pipeline by Allinky Biopharma SL, H2 2018
Alzheimer's Disease - Pipeline by ALSP Inc, H2 2018
Alzheimer's Disease - Pipeline by Alzhyme Pty Ltd, H2 2018
Alzheimer's Disease - Pipeline by Alzinova AB, H2 2018
Alzheimer's Disease - Pipeline by AlzProtect SAS, H2 2018
Alzheimer's Disease - Pipeline by Amarantus Bioscience Holdings Inc, H2 2018
Alzheimer's Disease - Pipeline by Amgen Inc, H2 2018
Alzheimer's Disease - Pipeline by Anavex Life Sciences Corp, H2 2018
Alzheimer's Disease - Pipeline by Annexon Inc, H2 2018
Alzheimer's Disease - Pipeline by Aphios Corp, H2 2018
Alzheimer's Disease - Pipeline by Apodemus AB, H2 2018
Alzheimer's Disease - Pipeline by Applied Research using OMIC Sciences SL, H2 2018
Alzheimer's Disease - Pipeline by Araclon Biotech SL, H2 2018
Alzheimer's Disease - Pipeline by Archer Pharmaceuticals Inc, H2 2018
Alzheimer's Disease - Pipeline by ArmaGen Inc, H2 2018
Alzheimer's Disease - Pipeline by Asceneuron SA, H2 2018
Alzheimer's Disease - Pipeline by AstraZeneca Plc, H2 2018
Alzheimer's Disease - Pipeline by Aucta Pharmaceuticals LLC, H2 2018
Alzheimer's Disease - Pipeline by Auritec Pharmaceuticals Inc, H2 2018
Alzheimer's Disease - Pipeline by Avanir Pharmaceuticals Inc, H2 2018
Alzheimer's Disease - Pipeline by Avineuro Pharmaceuticals Inc, H2 2018
Alzheimer's Disease - Pipeline by Axon Neuroscience SE, H2 2018
Alzheimer's Disease - Pipeline by Axovant Sciences Ltd, H2 2018
Alzheimer's Disease - Pipeline by Axsome Therapeutics Inc, H2 2018
Alzheimer's Disease - Pipeline by Axxam SpA, H2 2018
Alzheimer's Disease - Pipeline by AZTherapies Inc, H2 2018
Alzheimer's Disease - Pipeline by Bactevo Ltd, H2 2018
Alzheimer's Disease - Pipeline by Beactica AB, H2 2018
Alzheimer's Disease - Pipeline by Berg LLC, H2 2018
Alzheimer's Disease - Pipeline by BioArctic AB, H2 2018
Alzheimer's Disease - Pipeline by Biogen Inc, H2 2018
Alzheimer's Disease - Pipeline by Biohaven Pharmaceutical Holding Company Ltd, H2 2018
Alzheimer's Disease - Pipeline by BioHealthonomics Inc, H2 2018
Alzheimer's Disease - Pipeline by BioXcel Therapeutics Inc, H2 2018
Alzheimer's Disease - Pipeline by Boehringer Ingelheim GmbH, H2 2018
Alzheimer's Disease - Pipeline by Bolder Biotechnology Inc, H2 2018
Alzheimer's Disease - Pipeline by Boryung Pharmaceutical Co Ltd, H2 2018
Alzheimer's Disease - Pipeline by Bristol-Myers Squibb Co, H2 2018
Alzheimer's Disease - Pipeline by Bsim2, H2 2018
Alzheimer's Disease - Pipeline by Cantabio Pharmaceuticals Inc, H2 2018
Alzheimer's Disease - Pipeline by Cardax Inc, H2 2018
Alzheimer's Disease - Pipeline by Carna Biosciences Inc, H2 2018
Alzheimer's Disease - Pipeline by Celon Pharma SA, H2 2018
Alzheimer's Disease - Pipeline by CHA Bio & Diostech Co Ltd, H2 2018
Alzheimer's Disease - Pipeline by Clera Inc, H2 2018
Alzheimer's Disease - Pipeline by Cognition Therapeutics Inc, H2 2018
Alzheimer's Disease - Pipeline by Cognosci Inc, H2 2018
Alzheimer's Disease - Pipeline by CohBar Inc, H2 2018
Alzheimer's Disease - Pipeline by Corium International Inc, H2 2018
Alzheimer's Disease - Pipeline by Coronis NeuroSciences Ltd, H2 2018
Alzheimer's Disease - Pipeline by Cortice Biosciences Inc, H2 2018
Alzheimer's Disease - Pipeline by Cotinga Pharmaceuticals Inc, H2 2018

List of Figures
Number of Products under Development for Alzheimer's Disease, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Number of Products by Top 10 Targets, H2 2018
Number of Products by Stage and Top 10 Targets, H2 2018
Number of Products by Top 10 Mechanism of Actions, H2 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018
Number of Products by Top 10 Routes of Administration, H2 2018
Number of Products by Stage and Top 10 Routes of Administration, H2 2018
Number of Products by Top 10 Molecule Types, H2 2018
Number of Products by Stage and Top 10 Molecule Types, H2 2018
  • Insomnia - Pipeline Review, H2 2018
    Published: 09-Oct-2018        Price: US 2000 Onwards        Pages: 116
    Insomnia - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Insomnia - Pipeline Review, H2 2018, provides an overview of the Insomnia (Central Nervous System) pipeline landscape. Insomnia is a sleep disorder that is characterized by difficulty falling and/or staying asleep. Symptoms include difficulty falling asleep at night, irritability, depression or anxiety, tension headaches and distre......
  • Narcolepsy - Pipeline Review, H2 2018
    Published: 09-Oct-2018        Price: US 2000 Onwards        Pages: 88
    Narcolepsy - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Narcolepsy - Pipeline Review, H2 2018, provides an overview of the Narcolepsy (Central Nervous System) pipeline landscape. Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks. Symptoms of narcolepsy include excessive daytime sleepiness (EDS), cataplexy, hallucinations and sleep paral......
  • Spinal Cord Injury - Pipeline Review, H2 2018
    Published: 09-Oct-2018        Price: US 2000 Onwards        Pages: 199
    Spinal Cord Injury - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinal Cord Injury - Pipeline Review, H2 2018, provides an overview of the Spinal Cord Injury (Central Nervous System) pipeline landscape. Spinal cord injury (SCI) is defined as damage or trauma caused to the spinal cord. SCI can lead to loss or impaired function resulting in reduced mobility or feeling. It is usually cau......
  • Guillain-Barre Syndrome - Pipeline Review, H2 2018
    Published: 09-Oct-2018        Price: US 2000 Onwards        Pages: 51
    Guillain-Barre Syndrome - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Guillain-Barre Syndrome - Pipeline Review, H2 2018, provides an overview of the Guillain-Barre Syndrome (Central Nervous System) pipeline landscape. Guillain-Barre syndrome (GBS) is a disorder in which the body's immune system attacks part of the peripheral nervous system. The first symptoms of this disorder include ......
  • Low Back Pain - Pipeline Review, H2 2018
    Published: 09-Oct-2018        Price: US 2000 Onwards        Pages: 113
    Low Back Pain - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Low Back Pain - Pipeline Review, H2 2018, provides an overview of the Low Back Pain (Central Nervous System) pipeline landscape. Low back pain can happen anywhere below the ribs and above the legs. Causes of low back pain include overuse, strain, or injury, aging, arthritis, illness and cancer involving the spine. Symptoms inc......
  • Binge Eating Disorder - Pipeline Review, H2 2018
    Published: 09-Oct-2018        Price: US 2000 Onwards        Pages: 50
    Binge Eating Disorder - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Binge Eating Disorder - Pipeline Review, H2 2018, provides an overview of the Binge Eating Disorder (Central Nervous System) pipeline landscape. Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family hist......
  • Rett Syndrome - Pipeline Review, H2 2018
    Published: 09-Oct-2018        Price: US 2000 Onwards        Pages: 122
    Rett Syndrome - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rett Syndrome - Pipeline Review, H2 2018, provides an overview of the Rett Syndrome (Central Nervous System) pipeline landscape. Rett syndrome is a neurodevelopmental disorder. This is caused by genetic mutation on MECP2 gene. Rett syndrome is described in four stages: Stage I or early onset, Stage II or rapid destruction, Sta......
  • Pain Drug Development Pipeline Review, 2018
    Published: 24-Sep-2018        Price: US 3995 Onwards        Pages: 148
    This report provides an overview of the pipeline landscape for pain disorders. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for post-operative pain, fibromyalgia, complex regional pain syndrome (CRPS) and visceral pain, and features dormant and discontinued products. Pain is one of the main post-operative adverse outcomes causing distress to patients. Causes of post-operative pain include peripheral ner......
  • Depression and Anxiety Disorders Drug Development Pipeline Review, 2018
    Published: 21-Sep-2018        Price: US 3995 Onwards        Pages: 175
    Depression and Anxiety Disorders Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for depression and anxiety disorders. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD) and depression, and features dormant and discontinued products. PTSD is......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs